Nucletron and Advanced Radiation Therapy (ART) Jointly Announce a Global, Strategic Partnership to Offer AccuBoost® for Image-Guided Breast Irradiatio

COLUMBIA, MD and BILLERICA, MA (February 12, 2009) — Nucletron, a knowledge-based leader in radiation oncology, and Advanced Radiation Therapy (ART) announced today an exclusive global, strategic partnership to offer the AccuBoost® system with the microSelectron® high-dose rate (HDR) brachytherapy afterloader treatment delivery solution for the treatment of breast cancer. The partnership will enable clinicians all over the world to deliver boost brachytherapy as part of the whole breast irradiation procedure, providing a superior treatment option with the ultimate goal of improving clinical outcome.

The partnership offers radiation oncology centers the opportunity to implement ART’s innovative technology in image-guided HDR breast brachytherapy on a pay-per-patient pricing model, along with a full complement of Nucletron’s treatment planning, treatment delivery, training, licensing, reimbursement, and customized service support. ART’s expansion of AccuBoost technology through its global partnership with Nucletron will further reduce the barriers to adoption of brachytherapy for cancer centers previously deterred by the initial start-up costs usually associated with implementing a breast brachytherapy program.

source: Nucletron